MARX Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-83.01	-96.83	-12.92	2.83	4.43
Depreciation & Amortization	20.98	17.43	4.57	1.95	-
Other Amortization	1.14	0.54	0.02	-	-
Loss (Gain) From Sale of Assets	-	-	-	0.1	-
Loss (Gain) on Equity Investments	-	-	-	-	-4.97
Provision & Write-off of Bad Debts	-2.14	7.61	2.89	0.99	-
Other Operating Activities	-1.12	-1.11	-5.82	-2.04	-0.14
Change in Accounts Receivable	43.1	-26.77	-40.84	5.04	-
Change in Inventory	-105.1	-84.92	-6.65	-2.98	-
Change in Accounts Payable	40.74	65.06	3.13	-1.05	0.89
Change in Unearned Revenue	-77.52	10.34	14.82	-	-
Change in Other Net Operating Assets	16.94	1.45	23.66	6.59	0.11
Operating Cash Flow	-145.67	-107.18	-17.13	11.44	0.31
Operating Cash Flow Growth	-	-	-	3566.35%	-
Capital Expenditures	-210.49	-206	-1.04	-0.7	-
Sale of Property, Plant & Equipment	0.24	0.24	-	-	-
Cash Acquisitions	-114.77	-67.67	-72.39	0.18	-
Sale (Purchase) of Intangibles	-11.62	-12.56	-0.7	-	-
Investment in Securities	-2	-3.5	-	-	-
Other Investing Activities	2.36	3.01	-0.97	-0.28	-0.05
Investing Cash Flow	-336.28	-286.48	-75.1	-0.79	-0.05
Short-Term Debt Issued	-	98	-	10	-
Long-Term Debt Issued	-	170.31	-	-	-
Total Debt Issued	388.26	268.31	-	10	-
Short-Term Debt Repaid	-	-	-25.99	-	-
Long-Term Debt Repaid	-	-2.81	-1.85	-1.7	-
Total Debt Repaid	-28.32	-2.81	-27.85	-1.7	-
Net Debt Issued (Repaid)	359.94	265.5	-27.85	8.3	-
Issuance of Common Stock	50	50	251.76	-	-
Common Dividends Paid	-	-	-6.59	-7.35	-
Financing Cash Flow	409.94	315.5	217.33	0.95	-
Net Cash Flow	-72	-78.16	125.1	11.6	0.27
Free Cash Flow	-356.16	-313.18	-18.17	10.74	0.31
Free Cash Flow Growth	-	-	-	3343.27%	-
Free Cash Flow Margin	-49.96%	-50.66%	-6.27%	9.71%	-
Free Cash Flow Per Share	-0.71	-0.63	-0.06	0.03	0.01
Cash Interest Paid	7.93	2.21	0.37	0.11	-
Cash Income Tax Paid	-	0.08	4.65	4.12	-
Levered Free Cash Flow	-381.83	-292.53	-58.58	-38.72	-
Unlevered Free Cash Flow	-376.44	-291.14	-58.34	-38.65	-
Change in Working Capital	-81.84	-34.83	-5.88	7.61	0.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.